54 related articles for article (PubMed ID: 9565226)
1. Gestational age can predict the need for prophylaxis with surfactant therapy.
Mbuyamba M; Holman M; Kresch MJ
Am J Perinatol; 1998 Apr; 15(4):263-7. PubMed ID: 9565226
[TBL] [Abstract][Full Text] [Related]
2. Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates.
Fiori HH; Fritscher CC; Fiori RM
J Perinat Med; 2006; 34(1):66-70. PubMed ID: 16489887
[TBL] [Abstract][Full Text] [Related]
3. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
[TBL] [Abstract][Full Text] [Related]
4. Endotracheal continuous positive airway pressure after rescue surfactant therapy.
Mandy GT; Moïse AA; Smith EO; Hansen TN
J Perinatol; 1998; 18(6 Pt 1):444-8. PubMed ID: 9848758
[TBL] [Abstract][Full Text] [Related]
5. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
6. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
[TBL] [Abstract][Full Text] [Related]
8. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.
Kwong MS; Egan EA; Notter RH; Shapiro DL
Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906
[TBL] [Abstract][Full Text] [Related]
9. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
10. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams.
Kresch MJ; Clive JM
J Perinatol; 1998; 18(4):276-83. PubMed ID: 9730197
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
Modanlou HD; Beharry K; Padilla G; Iriye B
J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
[TBL] [Abstract][Full Text] [Related]
13. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
[TBL] [Abstract][Full Text] [Related]
14. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
Harker LC; Merritt TA; Edwards DK
J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
[TBL] [Abstract][Full Text] [Related]
15. Increased survival in low birth weight neonates given prophylactic surfactant.
Brown DR; Bloom BT; Cohen M; Myers MM; Egan EA; Kattwinkel J; Delmore P; Hall RT; Malloy MH; Holzman IR; Carlo WA; Pramanik AK; McCaffree MA; Weatherstone KB; Willett LD; Topper WH
J Perinatol; 1998; 18(6 Pt 1):431-5. PubMed ID: 9848755
[TBL] [Abstract][Full Text] [Related]
16. Surfactant therapy prior to the interhospital transport of preterm infants.
Costakos D; Allen D; Krauss A; Ruiz N; Fluhr K; Stouvenel A; Paxson C
Am J Perinatol; 1996 Jul; 13(5):309-16. PubMed ID: 8863952
[TBL] [Abstract][Full Text] [Related]
17. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
[TBL] [Abstract][Full Text] [Related]
18. Very low birth weight infants--mortality and predictive risk factors.
Chye JK; Lim CT
Singapore Med J; 1999 Sep; 40(9):565-70. PubMed ID: 10628243
[TBL] [Abstract][Full Text] [Related]
19. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of the limit of viability: neonatologists' attitudes toward extremely preterm infants.
Sanders MR; Donohue PK; Oberdorf MA; Rosenkrantz TS; Allen MC
J Perinatol; 1995; 15(6):494-502. PubMed ID: 8648459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
